Document is current

Any future updates will be listed below

Efficacy and safety of pateclizumab (anti-lymphotoxin-α) compared to adalimumab in rheumatoid arthritis: a head-to-head phase 2 randomized controlled study (The ALTARA Study)

Crossref DOI link: https://doi.org/10.1186/s13075-014-0467-3

Published Online: 2014-10-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark